✨ Your Portfolio is fetched and updated from zerodha.
Small Pharmaceuticals

JB Chemicals & Pharmaceuticals Ltd.

JBCHEPHARM

Market Cap
₹27,045 Cr.
P/E
41.00

JB Chemicals & Pharmaceuticals Ltd.

  • JB Chem & Pharma
  • Pfizer
  • Astrazeneca Pharma I
  • TJI Pharma - Small Cap
FAQs on JB Chemicals & Pharmaceuticals Ltd. Shareprice

JB Chem & Pharma has given better returns compared to its competitors.
JB Chem & Pharma has grown at ~22.41% over the last 4yrs while peers have grown at a median rate of 19.48%

Yes, JB Chem & Pharma is expensive.
Latest PE of JB Chem & Pharma is 41.0, while 3 year average PE is 38.8.
Also latest EV/EBITDA of JB Chem & Pharma is 26.1 while 3yr average is 25.48.

View FAQ's On Business
Growth Table
  • JB Chemicals & Pharmaceuticals Ltd.
  • Pfizer
  • Astrazeneca Pharma I
Balance Sheet
  • JB Chemicals & Pharmaceuticals Ltd.
  • Pfizer
  • Astrazeneca Pharma I
Balance Sheet Snapshot
No data available.
Fund Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end
Profit & Loss
  • JB Chemicals & Pharmaceuticals Ltd.
  • Pfizer
  • Astrazeneca Pharma I
Cash Flow
  • JB Chemicals & Pharmaceuticals Ltd.
  • Pfizer
  • Astrazeneca Pharma I
Cash Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
Ratios
= Dominant Factor
  • JB Chemicals & Pharmaceuticals Ltd.
  • Pfizer
  • Astrazeneca Pharma I
Quarterly Results
  • JB Chemicals & Pharmaceuticals Ltd.
  • Pfizer
  • Astrazeneca Pharma I
Reverse DCF
locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Raphson method.
Learn how to use Reverse DCF
FAQs on JB Chemicals & Pharmaceuticals Ltd. Financials

Balance sheet of JB Chem & Pharma is strong.
It shouldn't have solvency or liquidity issues.

The net debt of JB Chem & Pharma is decreasing.
Latest net debt of JB Chem & Pharma is -₹115.65 Crs as of Mar-25.
This is less than Mar-24 when it was ₹166 Crs.

Yes, profit is increasing.
The profit of JB Chem & Pharma is ₹660 Crs for TTM, ₹553 Crs for Mar 2024 and ₹410 Crs for Mar 2023.

The company seems to pay a good stable dividend.
JB Chem & Pharma latest dividend payout ratio is 34.4% and 3yr average dividend payout ratio is 33.67%

Companies resources are allocated to majorly unproductive assets like Cash & Short Term Investments, Short Term Loans & Advances

View FAQ's On Shareholding
Ideas Dashboard
Timeline
Watchlist
Portfolio
Alerts
Research
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech